Literature DB >> 2493678

Structure of recombinant human renin, a target for cardiovascular-active drugs, at 2.5 A resolution.

A R Sielecki1, K Hayakawa, M Fujinaga, M E Murphy, M Fraser, A K Muir, C T Carilli, J A Lewicki, J D Baxter, M N James.   

Abstract

The x-ray crystal structure of recombinant human renin has been determined. Molecular dynamics techniques that included crystallographic data as a restraint were used to improve an initial model based on porcine pepsinogen. The present agreement factor for data from 8.0 to 2.5 angstroms (A) is 0.236. Some of the surface loops are poorly determined, and these disordered regions border a 30 A wide solvent channel. Comparison of renin with other aspartyl proteinases shows that, although the structural cores and active sites are highly conserved, surface residues, some of which are critical for specificity, vary greatly (up to 10A). Knowledge of the actual structure, as opposed to the use of models based on related enzymes, should facilitate the design of renin inhibitors.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2493678     DOI: 10.1126/science.2493678

Source DB:  PubMed          Journal:  Science        ISSN: 0036-8075            Impact factor:   47.728


  31 in total

1.  Analysis of crystal structures of aspartic proteinases: on the role of amino acid residues adjacent to the catalytic site of pepsin-like enzymes.

Authors:  N S Andreeva; L D Rumsh
Journal:  Protein Sci       Date:  2001-12       Impact factor: 6.725

2.  Renin and cardiovascular disease: Worn-out path, or new direction.

Authors:  Gaurav Alreja; Jacob Joseph
Journal:  World J Cardiol       Date:  2011-03-26

Review 3.  Molecular recognition: models for drug design.

Authors:  R J Breckenridge
Journal:  Experientia       Date:  1991-12-01

4.  Active prorenin: evidence for the formation of a conformational variant of recombinant human prorenin.

Authors:  R Edalji; T F Holzman; E J Gubbins
Journal:  J Protein Chem       Date:  1991-08

5.  Characterization of recombinant human renin: kinetics, pH-stability, and peptidomimetic inhibitor binding.

Authors:  T F Holzman; C C Chung; R Edalji; D A Egan; M Martin; E J Gubbins; G A Krafft; G T Wang; A M Thomas; S H Rosenberg
Journal:  J Protein Chem       Date:  1991-10

Review 6.  Direct renin inhibition: an analysis of possible benefits.

Authors:  Brian K Dockery; John D Bisognano
Journal:  Curr Hypertens Rep       Date:  2008-08       Impact factor: 5.369

Review 7.  Overview of protein structural and functional folds.

Authors:  Peter D Sun; Christine E Foster; Jeffrey C Boyington
Journal:  Curr Protoc Protein Sci       Date:  2004-05

Review 8.  Molecular mechanisms for the conversion of zymogens to active proteolytic enzymes.

Authors:  A R Khan; M N James
Journal:  Protein Sci       Date:  1998-04       Impact factor: 6.725

9.  Deglycosylation of proteins for crystallization using recombinant fusion protein glycosidases.

Authors:  F Grueninger-Leitch; A D'Arcy; B D'Arcy; C Chène
Journal:  Protein Sci       Date:  1996-12       Impact factor: 6.725

10.  Structure and inhibition of plasmepsin II, a hemoglobin-degrading enzyme from Plasmodium falciparum.

Authors:  A M Silva; A Y Lee; S V Gulnik; P Maier; J Collins; T N Bhat; P J Collins; R E Cachau; K E Luker; I Y Gluzman; S E Francis; A Oksman; D E Goldberg; J W Erickson
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-17       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.